USPTO serial 97098413
UP&UP
Reviewed by CopyMark Law Group
Status 819
- Filing date
- Status date
- Registration date
- —
- Examiner
- FREEMAN, BREANNA SHALEISE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with UP&UP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Minneapolis, MN, US
Minneapolis, MN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Renee S. Kraft
Renee S. Kraft TARGET BRANDS, INC.1000 NICOLLET MALL, TPS-3165MINNEAPOLIS, MN 55403United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cleaning preparations for household purposes; laundry detergent; fabric softeners and conditioners for laundry use; all-purpose drain openers; automatic and liquid dishwashing detergents and additives, namely, dishwashing detergents and laundry additives for water softening; cleaning preparations for carpets, rugs and upholstery; disposable wipes impregnated with cleansing chemicals or compounds for household use; hair shampoo and hair conditioner; baby bath cleansers, namely, baby bubble bath, bath soaps; baby lotion; baby oil, baby oil gel and creamy baby oil; baby powder and cornstarch baby powder; baby shampoo; baby wipes impregnated with cleaning preparations; cosmetic pads and cosmetic sponges; cotton swabs, sticks, balls, and puffs for personal cosmetic use; non-medicated diaper rash ointment; disposable wipes impregnated with cleansing chemicals or compounds for personal hygiene; non-medicated foot powder; petroleum jelly for cosmetic purposes; skin care preparations, namely, body wash, body powder, body scrub, hand cream, and skin lotion; liquid skin soap; bath and shower gel; bubble bath; shaving foam; shaving gel, shave cream; lip balm; sunscreen preparations, namely, sunscreen lotions, sprays and creams; cleaners and cleansers, namely, glass cleaners, all-purpose cleaners, hand cleaners, skin cleansers, face cleansers, cosmetic cleansing creams; breath fresheners, namely, breath freshening preparations for personal hygiene; mouthwash, not for medical purposes; toothpaste; tooth gel, namely, tooth whitening gels, tooth cleaning gels; teeth cleaning preparations; tooth whitening preparations; room fragrances; nail polish removers; non-medicated pet shampoos and conditioners; deodorizers for pets; air fragrancing preparations | ACTIVE | — |
| 005 | Alcohol for topical use and alcohol for medicinal purposes, namely, alcohol swabs for topical use, alcohol-prepared pads in the nature of disposable pads impregnated with alcohol for medical and topical use; adhesive bandages; air fresheners and room deodorizers, namely, air deodorizing preparations and room deodorants; alcohol for topical use; all-purpose disinfectants; analgesics and pain relievers in the nature of pain relief medication; anti-bacterial and anti-microbial soap for dermatologic use; antibiotic creams and ointments; antifungal preparations for personal use; anti-itch creams, lotions, and ointments; antiseptic and medicated mouthwashes; carpet and room deodorizers; disinfectants, namely, disinfectant mildew removers; electrolyte replacement solutions; Epsom salts; feminine hygiene and protection, namely, tampons, feminine hygiene maxi pads, feminine hygiene mini pads, and panty liners; gauze; hemorrhoid treatment preparations; hand sanitizing and disinfecting preparations; household disinfectants with cleaning, deodorizing and germicidal properties; hydrocortisone creams and ointments; hydrogen peroxide for medical use; infant formula; medicated shampoo; medical adhesive tape; medicated diaper rash ointment; medicated foot powder; medicated body powder; medicated pre- moistened wipes; non-adhesive bandages and adhesives for bandages for skin wounds; odor eliminators for use on fabrics, namely, fabric deodorizers; medicated ointments for the prevention and treatment of diaper rash and dermatological conditions; ophthalmic preparations, namely, eye drops, eye drops containing antihistamines and decongestants, lubricating and rewetting solutions, sterile saline solution, and therapeutic ophthalmic preparations; ophthalmic solutions for use with contact lenses, namely, contact lens cleaners, contact lens soaking, wetting and disinfecting solutions; ovulation test kits; petroleum jelly for medical purposes; pharmaceutical preparations, namely, allergy relief medications, analgesics and pain relievers in the nature of pain relief medication, analgesic sleeping aids, antihistamines, aspirin, cold medications in the nature of preparations for treating colds; cough treatment medications and suppressants, namely, cough treatment preparations; decongestants, fever reducers in the nature of pharmaceutical preparations for treating fevers, flu medications in the nature of pharmaceutical preparations for treating the flu, menstrual pain and cramp relievers in the nature of pain relief medication; motion sickness treatment preparations, nasal spray preparations, pharmaceutical preparations for the treatment of asthma and hay fever; respiratory infection medications, namely, pharmaceutical preparations for treating respiratory infections; sinus medications in the nature of pharmaceutical preparations for treating sinus discomfort, medicated and natural sleep-aid preparations, throat lozenges, cough drops; pharmaceutical preparations, namely, antacids, acid reducers in the nature of antacids, anti-gas preparations in the nature of pharmaceutical preparations for treating gas, anti-diarrhea preparations in the nature of diarrhea medication, laxatives, lactose intolerance preparations in the nature of pharmaceutical preparations for treating lactose intolerance, mineral oil in the nature of medicated oil containing minerals, stool softeners; pharmaceutical preparations for the treatment, relief, and prevention of gastrointestinal distress, gastrointestinal disorders, constipation; pregnancy test kits for home use; preparations for disinfecting floors; smoking cessation preparations; supplements, namely, vitamin, mineral, dietary, herbal, nutritional, and homeopathic supplements; nutritionally fortified beverages for medical purposes; witch hazel; acne medications; acne treatment preparations; first aid kits; nail fungus treatment preparations; digestives for pharmaceutical purposes; moleskin for medical purposes; nursing pads; non- medicated acne treatment preparations | ACTIVE | — |
| 010 | Gloves for medical use; thermometers for medical use; elastic bandages; compression bandages; pill cutters; orthotic inserts for footwear | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 27, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 6, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 11, 2026 | IUAF | USE AMENDMENT FILED | — |
| Sep 11, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 23, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 23, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 22, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 12, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 12, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 12, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 11, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 11, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 11, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 11, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 11, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 11, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 28, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 28, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 28, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 28, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 13, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 12, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 12, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 12, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 12, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 18, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 18, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 28, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2023 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 5, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2023 | ALIE | ASSIGNED TO LIE | — |
| Feb 9, 2023 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Feb 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2023 | PETG | PETITION TO REVIVE-GRANTED | — |
| Feb 9, 2023 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Aug 5, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 11, 2021 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 1, 2021 | NWAP | NEW APPLICATION ENTERED | — |